Health Lifestyle

GET RIPPED by Jari Love – Mar 2025

Weight Loss Injections the Truth Behind the Hype

In North America’s battle with weight, one solution is dominating headlines— weight loss injections. From Oprah calling it a ‘lifesaver’ to Elon Musk swearing by its power, celebrities are shedding pounds fast. More than vanity, it’s health, confidence, and control. Is this the game-changer we’ve all been waiting for?

Dr. Peter, MB BS, MD, IAPAM, an expert on the weight loss injections, took the time to break down how GLP-1 medications work, and why they’re not just about dropping pounds but about long-term health. In this interview, Dr. Peter answers some of the most common questions about GLP-1 medications.

Q: What are GLP-1 medications, and how do they work for weight loss?
A: GLP-1 (Glucagon-Like Peptide-1) medications mimic a natural hormone in the body that helps control blood sugar, reduce appetite, and slow digestion. This results in eating less and feeling full longer, leading to weight loss.

Q: What is the difference between Ozempic, Wegovy, and Mounjaro?
A:

  • Ozempic – Treats type 2 diabetes; often used off-label for weight loss.
  • Wegovy – The same medication as Ozempic (semaglutide) but at a higher dose, specifically approved for weight loss.
  • Mounjaro – Works on two hormones (GLP-1 and GIP) instead of one, leading to potentially greater weight loss.

Q: What are the top 3 benefits of taking GLP-1 medications like Wegovy?
A:

  1. Significant Weight Loss – Wegovy helps regulate appetite and reduce food intake by mimicking the GLP-1 hormone, leading to substantial and sustained weight loss.
  2. Improved Metabolic Health – It enhances insulin sensitivity, lowers blood sugar levels, and reduces the risk of type 2 diabetes, making it beneficial for overall metabolic health.
  3. Cardiovascular Protection – Studies suggest that GLP-1 medications lower the risk of heart disease by reducing inflammation, improving lipid profiles, and lowering blood pressure.

Q: How much weight can I expect to lose with these medications?
A: Wegovy users lose about 5-10% of their body weight on average. Mounjaro shows even higher weight loss in studies, up to 15-20 % over a 12-week period as per Health Canada guidelines.

Q: How soon do you start losing weight after starting the medication?
A: Weight loss is variable as no two individuals see exact results in view of genetics and environmental factors (diet and exercise with motivational support ). However, weight loss often begins within the first month, but significant changes are typically seen after 12-16 weeks of consistent use and close monitoring under supervision of a MD trained in weight loss medicine.

Q: What are the common side effects of GLP-1 medications, and are they safe for long-term use?
A: Common side effects: nausea, vomiting, diarrhea, constipation, and bloating. Most side effects are mild and improve over time. Long-term safety: Studies suggest these medications are generally safe, but like everything in life, more research is needed on lifelong maintenance use.

Q: Are there risks of developing serious complications taking any of these medications?
A: Rare risks include pancreatitis, gallstones, and thyroid cancer. Regular checkups and close monitoring with a doctor minimize these risks.

Q: Can I lose weight on GLP-1 medications even with an unhealthy diet?
A: Weight loss is possible but less effective and sustainable without healthy habits and life style changes. It is highly recommended on combining the medication with a healthy diet and exercise maximizes results and maintenance.

Q: Will I plateau, and how can I overcome it if I do?
A: Plateaus are common after significant weight loss. Overcome them by close regular checkups with the MD, tweaking your diet, increasing exercise, and consulting your doctor about dosage adjustments.

Q: What happens if I stop taking the medication, will I regain the weight?
A: Weight regains is likely unless lifestyle changes are sustained.

Q: Can I maintain weight loss by sticking to a low-calorie diet and exercising after stopping?
A: Yes, but it requires consistent effort, close monitoring and planning. Obesity is a recognized chronic medical condition like hypertension and diabetes.

Q: Are these medications intended for lifelong use?
A: They are often recommended for long-term maintenance use in managing obesity, Type 2 diabetes mellitus and other chronic related health issues, with direct correlation with excess weight gain. Recent studies have shown increase benefits, using these medications, in preventing heart attacks and stroke.

Q: Why do these medications work so well for some people but not others?
A: Differences in genetics, metabolism, and lifestyle influence effectiveness.

Q: What alternatives are available if I can’t take GLP-1 medications?
A: Alternatives: Low-calorie diets, exercise programs, other medications (e.g., Contrave, Saxenda), or bariatric surgery. Newer medications are in the horizon as well.

Q: Can these medications be combined with other treatments for even better results?
A: Yes, combining them with behavioral therapy, structured exercise programs, non-invasive fat destruction medical devices and low-calorie meal plans have been shown to enhance outcomes.

GLP-1 medications are a powerful tool for weight loss, but success depends on the right approach. If you’re considering GLP-1 therapy, consult with a qualified physician, and pair it with sustainable nutrition, exercise, and muscle-preserving strategies for lasting results.

Jari Love is a certified trainer and creator of the successful scientifically tested Get RIPPED!® series. You can learn more about Jari Love at www.jarilove.com. You can follow her on Facebook at @JariLoveFitness and at @rippedjari on Instagram.

About the author

Jari Love

Jari Love is a certified trainer and creator of the successful scientifically tested Get RIPPED!® series. You can learn more about Jari Love at www.jarilove.com. You can follow her on Facebook at @JariLoveFitness and at @rippedjari on Instagram.

Support Local Business

Support Local Business